Lexicon Pharmaceuticals (LXRX) Intangibles (2010 - 2020)
Lexicon Pharmaceuticals (LXRX) posted quarterly Intangibles of $18.8 million for Q2 2020, down 61.75% year-over-year from $49.2 million in Q3 2019, and down 2.29% quarter-over-quarter from $19.3 million in Q1 2020.
Lexicon Pharmaceuticals (LXRX) Intangibles (2010 - 2020) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Intangibles for 11 consecutive years, with $18.8 million the latest figure, recorded in Q2 2020.
- In Q2 2020, Intangibles fell 61.75% year-over-year to $18.8 million; the TTM figure through Jun 2020 stood at $18.8 million (down 61.75% YoY), while the FY2019 annual figure was $19.7 million, down 60.66% from the prior year.
- Intangibles slipped to $18.8 million in Q2 2020 per LXRX's latest filing, from $19.3 million in the prior quarter.
- Across five years, Intangibles topped out at $53.4 million in Q1 2016 and bottomed at $18.8 million in Q2 2020.
- Historically, Intangibles has averaged $43.1 million across 5 years, with a median of $50.8 million in 2018.
- Annual changes were most pronounced in 2018 — Intangibles soared 108.28% — and 2020, when it sank 61.75%.
- Lexicon Pharmaceuticals' Intangibles stood at $53.4 million in 2016, then retreated by 2.76% to $51.9 million in 2017, then retreated by 3.4% to $50.1 million in 2018, then plunged by 60.66% to $19.7 million in 2019, then dropped by 4.48% to $18.8 million in 2020.
- Business Quant data shows LXRX's Intangibles at $18.8 million in Q2 2020, $19.3 million in Q1 2020, and $19.7 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 18.83 Mn |
| Mar 31, 2020 | 19.28 Mn |
| Dec 31, 2019 | 19.72 Mn |
| Sep 30, 2019 | 20.16 Mn |
| Jun 30, 2019 | 49.24 Mn |
| Mar 31, 2019 | 49.68 Mn |
| Dec 31, 2018 | 50.12 Mn |
| Sep 30, 2018 | 50.56 Mn |
| Jun 30, 2018 | 51.00 Mn |
| Mar 31, 2018 | 51.44 Mn |
| Dec 31, 2017 | 51.89 Mn |
| Sep 30, 2017 | 52.33 Mn |
| Jun 30, 2017 | 52.77 Mn |
| Mar 31, 2017 | 24.70 Mn |
| Dec 31, 2016 | 53.36 Mn |
| Sep 30, 2016 | 53.36 Mn |
| Jun 30, 2016 | 53.36 Mn |
| Mar 31, 2016 | 53.36 Mn |
| Dec 31, 2015 | 53.36 Mn |
| Sep 30, 2015 | 53.36 Mn |